Increasing number of road accidents leading to facial injuries, and rise in the cases of genetic facial deformities are the major factors contributing to the growth of the global craniomaxillofacial implants market. In terms of regional classification, the global craniomaxillofacial implants market has been segmented into six major markets: North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World (RoW). North America accounted for the largest share of the global craniomaxillofacial implants market in 2013, followed by Asia Pacific. According to the American Academy of Otolaryngology – Head and Neck Surgery, about three million people are treated in emergency departments for facial trauma injuries each year in the U.S. Thus, rising cases of facial traumas and injuries clearly emphasize the need for efficient craniomaxillofacial implants in North America.
Get the Sample Report Containing Future Analysis of Craniomaxillofacial Implants Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4861
In terms of revenue, North America was the largest regional market for craniomaxillofacial implants, and accounted for a share of over 50% of the global market in 2013. Dominance of North America has been attributed to increasing prevalence of facial deformities, implementation of technological platforms and intense governmental regulations relating to public health issues. Major types of craniomaxillofacial implants that contribute to the growth of the craniomaxillofacial implants market in North America include plate and screw fixator systems, bone graft substitutes, distraction systems, and temporomandibular joint (TMJ) replacement devices. Plate and screw fixator systems was the largest segment of the craniomaxillofacial implants market in North America in 2013.
Asia Pacific was the second largest market for craniomaxillofacial implants in terms of revenue in 2013, however, the region is expected to expand at the fastest CAGR of over 6.0% during the forecast period from 2014 to 2022. Factors attributed to the rapid growth of the craniomaxillofacial implants market in Asia Pacific are larger population base leading to high patient enrollment rate and implementation of government initiatives aimed at improving health care access. In addition, increase in the prevalence of facial abnormalities in the developing regions of Asia Pacific contribute towards the growth of craniomaxillofacial implants market in Asia Pacific. Each year, huge number of facial injury cases have been reported in countries such as India, China, Malaysia, Thailand, etc.
Europe was the third largest market for craniomaxillofacial implants market in 2013. Major European countries such as the U.K., Germany, France, Spain and Italy accounted for a majority share of the craniomaxillofacial implants market in Europe in 2013. According to an article published by the National Center for Biotechnology Information on European Maxillofacial Trauma (EURMAT) project in 2015, factors such as progressive ageing of the European population, reported occurrences of assaults, and falls are responsible for maxillofacial injuries in Europe. The craniomaxillofacial implants market in Latin America and the Middle East is expected to witness moderate growth. According to an article published by the National Center for Biotechnology Information (Journal name: Clinics) in 2010, implementation of traffic laws have provided numerous benefits to a number of cities in Latin America including Brazil and hence reduced the rate of road accidents.
DePuy Synthes, Stryker Corporation, Biomet, Inc., KLS Martin LP, Anatomics Pty. Ltd., BIOPORE Surgical Implants, Medartis AG, Matrix Surgical USA, OsteoMed, Medical Vision Australia Holdings, Rebstock Instruments GmbH, Poriferous, LLC, General Implants GmbH, Osteotec Ltd., B.Braun Melsungen AG, Medtronic, Inc. are the major players operating in the global craniomaxillofacial implants market. Among these, DePuy Synthes and Stryker Corporation are the market leaders.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453